Antonio Francavilla

Antonio Francavilla

Auto-generated profile, based on publicly available information

Antonio Francavilla

Italian Institute for Genomic Medicine (IIGM), Turin, Italy

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
ATAndrew Thomas
Andrew Thomas
PMPaolo Manghi
Paolo Manghi
Francesco AsnicarFrancesco Asnicar
Francesco Asnicar
Edoardo PasolliEdoardo Pasolli
Edoardo Pasolli
FAFederica Armanini
Federica Armanini
NSNicola Segata
Nicola Segata

29 October 2019 in mSystems
Verified
Journal Article
Open access
PDF file
STSonia Tarallo
Sonia Tarallo
Giulio FerreroGiulio Ferrero
Giulio Ferrero
GGGaetano Gallo
Gaetano Gallo
AFAntonio Francavilla
Antonio Francavilla
GCGiuseppe Clerico
Giuseppe Clerico
FCFRANCESCA CORDERO
FRANCESCA CORDERO
The characteristics of microbial small RNA transcription are largely unknown, while it is of primary importance for a better identification of molecules with functional activities in the gut niche under both healthy and disease conditions. By performing combined analyses of metagenomic and small RNA sequencing (sRNA-Seq) data, we characterized both the human and microbial small RNA contents of stool samples from healthy individuals and from patients with colorectal carcinoma or adenoma. With the integrative analyses of metagenomic and sRNA-Seq data, we identified a human and microbial small RNA signature which can be used to improve diagnosis of the disease. Our analysis of human and gut microbiome small RNA expression is relevant to generation of the first hypotheses about the potential molecular interactions occurring in the gut of CRC patients, and it can be the basis for further mechanistic studies and clinical tests.

7 February 2023 in Gut Microbes
Verified
Journal Article
Open access
AFAntonio Francavilla
Antonio Francavilla
Giulio FerreroGiulio Ferrero
Giulio Ferrero
Barbara PardiniBarbara Pardini
Barbara Pardini
STSonia Tarallo
Sonia Tarallo
LZLaura Zanatto
Laura Zanatto
ANAlessio Naccarati
Alessio Naccarati
Current treatment for celiac disease (CD) is adhering to a gluten-free diet (GFD), although its long-term molecular effects are still undescribed. New molecular features detectable in stool may improve and facilitate noninvasive clinical management of CD. For this purpose, fecal small non-coding RNAs (sncRNAs) and gut microbiome profiles were concomitantly explored in CD subjects in relation to strict (or not) GFD adherence over time. In this observational study, we performed small RNA and shotgun metagenomic sequencing in stool from 63 treated CD (tCD) and 3 untreated subjects as well as 66 sex- and age-matched healthy controls. tCD included 51 individuals on strict GFD and with negative transglutaminase (TG) serology (tCD-TG-) and 12 symptomatic with not strict/short-time of GFD adherence and positive TG serology (tCD-TG+). Samples from additional 40 healthy adult individuals and a cohort of 19 untreated pediatric CD subjects and 19 sex/age matched controls were analyzed to further test the outcomes. Several miRNA and microbial profiles were altered in tCD subjects (adj. p < .05). Findings were validated in the external group of adult controls. In tCD-TG-, GFD duration correlated with five miRNA levels (p < .05): for miR-4533-3p and miR-2681-3p, the longer the diet adherence, the less the expression differed from controls. tCD-TG+ and untreated pediatric CD patients showed a similar miRNA dysregulation. Immune-response, trans-membrane transport and cell death pathways were enriched in targets of identified miRNAs. Bifidobacterium longum, Ruminococcus bicirculans, and Haemophilus parainfluenzae abundances shifted (adj. p < .05) with a progressive reduction of denitrification pathways with GFD length. Integrative analysis highlighted 121 miRNA-bacterial relationships (adj. p < .05). Specific molecular patterns in stool characterize CD subjects, reflecting either the long-term GFD effects or the gut inflammatory status, in case of a not strict/short-time adherence. Our findings suggest novel host-microbial interplays and could help the discovery of biomarkers for GFD monitoring over time.

29 October 2019 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
ATAndrew Thomas
Andrew Thomas
PMPaolo Manghi
Paolo Manghi
Francesco AsnicarFrancesco Asnicar
Francesco Asnicar
Edoardo PasolliEdoardo Pasolli
Edoardo Pasolli
FAFederica Armanini
Federica Armanini
NSNicola Segata
Nicola Segata

10 November 2022 in Cancer Medicine
Verified
Journal Article
Open access
AGAmedeo Gagliardi
Amedeo Gagliardi
GFGiulia Francescato
Giulia Francescato
Giulio FerreroGiulio Ferrero
Giulio Ferrero
GBGiovanni Birolo
Giovanni Birolo
STSonia Tarallo
Sonia Tarallo
Barbara PardiniBarbara Pardini
Barbara Pardini
Background: The 8q24 locus is enriched in cancer‐associated polymorphisms and, despite containing relatively few protein‐coding genes, it hosts the MYC oncogene and other genetic elements connected to tumorigenesis, including microRNAs (miRNAs). Research on miRNAs may provide insights into the transcriptomic regulation of this multiple cancer‐associated region.Material and methods: We profiled all miRNAs located in the 8q24 region in 120 colorectal cancer (CRC) patients and 80 controls. miRNA profiling was performed on cancer/non‐malignant adjacent mucosa, stool, and plasma extracellular vesicles (EVs), and the results validated with The Cancer Genome Atlas (TCGA) data. To verify if the 8q24‐annotated miRNAs altered in CRC were dysregulated in other cancers and biofluids, we evaluated their levels in bladder cancer (BC) cases from the TCGA dataset and in urine and plasma EVs from a set of BC cases and healthy controls.Results: Among the detected mature miRNAs in the region, 12 were altered between CRC and adjacent mucosa (adj. p < 0.05). Five and four miRNAs were confirmed as dysregulated in the CRC and BC TCGA dataset, respectively. A co‐expression analysis of tumor/adjacent tissue data from the CRC group revealed a correlation between the dysregulated miRNAs and CRC‐related genes (PVT1 and MYC) annotated in 8q24 region. miR‐30d‐5p and miR‐151a‐3p, altered in CRC tissue, were also dysregulated in stool of CRC patients and urine of BC cases, respectively. Functional enrichment of dysregulated miRNA target genes highlighted terms related to TP53‐mediated cell cycle control.Conclusions: Altered expression of 8q24‐annotated miRNAs may be relevant for the initiation and/or progression of cancer.

1 March 1994 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
LPL. Polimeno
L. Polimeno
GSGianfranco Silecchia
Gianfranco Silecchia
ESE. Spaziani
E. Spaziani
ASA. Scucchi
A. Scucchi
PDP. Dell'AQuila
P. Dell'AQuila
AFA. Francavilla
A. Francavilla